The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Slow editing of protein blueprints leads to cell death, spliceosome study discovers
An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...
Blood Becomes Medicine in a Revolutionary Regeneration Breakthrough
Scientists have developed a groundbreaking ‘biocooperative’ material using blood that not only repairs bones but also enhances natural healing processes. This new material, created by combining ...